Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -4.364\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. CCOc1ccc(CCNC(=O)c2cc([N+](=O)[O-])ccc2N2CCOCC2)cc1OCC
b. O=C(NCCN1CCCCC1)Nc1ccccc1Cl
c. CCS(=O)(=O)N1CCN(c2c(Cl)cccc2[N+](=O)[O-])CC1
Answer: a. CCOc1ccc(CCNC(=O)c2cc([N+](=O)[O-])ccc2N2CCOCC2)cc1OCC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1ccc(CCNC(=O)c2cc([N+](=O)[O-])ccc2N2CCOCC2)cc1OCC
CCOc1ccc(CCNC(=O)c2cc([N+](=O)[O-])ccc2N2CCOCC2)cc1OCC
N-[2-(3,4-diethoxyphenyl)ethyl]-2-morpholin-4-yl-5-nitrobenzamide